TIBER CREEK GROUP

Lobbying for ASTRAZENECA

Filing 2nd Quarter - Report

2nd Quarter (Apr 1 - June 30) 2026 · House · Senate · $80,000.00 income · posted Jul 19, 2026

Bills named in this filing 1

Lobbying activity 4

Health Issues

Issues related to the 340B Program - Public Health Service Act (PL 78-410).

Foreign Relations

Issues related to the Department of Defense, Uniform Formulary Beneficiary Advisory Panel.

Defense

Issues related to H.R. 9102 - Biotech Investment National Security Act of 2026 (BINSA).

Medicare/Medicaid

Issues related to Medicare Part D and Part B Pricing Reform; Issues related to the Medicaid Pricing reform.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.